Ami Organics IPO
Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.
The company has developed over 450 pharma intermediates across 17 key therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It supplies its products to more than 150 customers (including international customers) directly in India and in 25 countries overseas i.e. Europe, USA, China, Israel, Japan, Latin America, etc. Laurus Labs, Cadila Healthcare, Cipla Ltd are some of the domestic customers whereas Organike s.r.l.a. Socio Unico, Fermion Oly, Medichem S.A. and Midas Pharma GmbH are some of the international customers.
The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar & Jhagadia, with an aggregate installed capacity of 6,060 MTPA.
Strength of Ami Organics
- One of the leading manufacturers of certain Pharma Intermediates i.e. Dolutegravir, Trazodone, Entacapone, Nintedanib, and Rivaroxaban.
- Strong and diversified product portfolio with 450+ Pharma Intermediates across 17 therapeutic areas.
- Extensive geographical presence and diversified customer base.
- Strong R&D, sales, and marketing capabilities
- Consistent financial performance track record.
Ami Organics IPO Details
IPO Opens on: 1 September 2021
IPO Closes on: 3 September 2021
Price Band: Rs 603-610 per share
Bid Lot: 24 shares and in multiples of 24 shares
Minimum Investment: Rs 14,640
Maximum Investment: Rs 190,320
IPO Size: Rs 569.64 Cr
Fresh issue: Rs 200.00 Cr
Offer for Sale: Rs 369.64 Cr
Retail Allocation: 35%
Employees Discount: Rs 0 per share
Ami Organics IPO TimeLine
Finalisation of Allotment: 8 September 2021
Initiation of Refunds: 9 September 2021
Transfer of Shares to Demat Account: 13 September 2021
Listing At: NSE & BSE
Listing Date: 14 September 2021
Financial Performance of (in Crores) Ami Organics
|Net margin (%)||10.3||12.2||15.5|
Ami Organics IPO Valuations
Face Value = Rs 10
Earnings Per Share (EPS) = Rs 17.14
PE Ratio = 35.2 – 35.6
Return on Net Worth (RONW) = 32.35%
Net Asset Value = 52.99 per share
Ami Organics Subscription Details as on 1 September 2021 till 11:00 am
|Category||Shares offered||Subscription (no. of times)|
|Day 1||Day 2||Day 3|
Grey Market Premium of Ami Organics IPO Day by Day
Grey market premium as on 30-08-2021 = Rs.45/Share
Grey market premium as on 29-08-2021 = Rs.55/Share
Grey market premium as on 28-08-2021 = Rs.55/Share
Grey market premium as on 27-08-2021 = Rs.50/Share
Grey market premium as on 26-08-2021 = Rs.0/Share
Grey market premium as on 25-08-2021 = Rs.0/Share